Unveiling Taiwan's Biologics Excellence - From Innovation to Manufacturing
Since its inception in 2012, Biologics World Taiwan has experienced remarkable success by gathering over 300 pioneers in the biologics industry from Taiwan and around the world. Dedicated to fostering the development and manufacturing of high-quality biologic drugs, vaccines, stem cells, and regenerative medicines in Taiwan for the global market, Biologics World Taiwan 2024 is poised to continue its impactful legacy.
This year's conference will delve into a spectrum of pivotal topics, including must-see innovations originating from Taiwan, best practices in clinical research and trials, optimization of upstream processing, cost reduction in downstream processes, advancements in CAR-T and stem cell therapy, compelling case studies in regenerative medicines, and more. The agenda promises the most comprehensive coverage of Taiwan's biologics development and manufacturing landscape.
By participating in the conference, attendees will have the opportunity to engage with key and emerging entities within Taiwan's Biologics and Vaccine space, including distinguished organizations such as PharmaEssentia, Eirgenix, Mycenax, Medigen Biotechnology Corp, Lumosa Therapeutics, and others. If Taiwan stands out as a region rich in opportunities within the bio-manufacturing, vaccine, and cell therapy sectors, then Biologics World Taiwan 2024 is the definitive event to attend.
Discover the latest developments in Taiwan's biologics manufacturing sector, spanning from current best R&D practices to the trajectory towards advanced manufacturing. Immerse yourself in recent, exclusive case studies and gain insights into the industry's key needs—all under one roof! Don't miss this opportunity to stay at the forefront of Taiwan's dynamic biologics landscape.
Explore the best practices of clinical development & trials with the ultimate goal of bringing new biologics products with proven therapeutic effect to the market. Learn how important the transition of preclinical research to clinical stages can mark a critical turning point of new biologics development.
Process optimization is the key success factor to develop biomanufacturing practices with high productivity and reduced cost. Immerse in the latest technology from Taiwan about the key practices to enhance productivity and speed in producing biologics.
The emerging CMO leaders from Taiwan are about to share their success stories with valuable insights and case studies to deliver the next generation manufacturing capabilities that Taiwan is providing to the world in making first class biologics products that can save millions of lives.
Antibody and Protein therapeutics are emerging as the most promising class of diagnostics to treat diseases in humans. Innovative sharing and case studies of effective antibody and protein treatments will be shared by the experts.
Innovative strategy of assay optimization, real time monitoring system with highest compromisation to quality control of biologics products to a direction of improving efficiency while advocating process automation are the keys to quicker market commercialization and regulatory compliance. Topics built around cost and process optimization with latest developments in analytics and quality to foster biologics enhancement.
Gain insights on the latest case studies of stem cell and regenerative medicine and recognize the potential of the cell and gene therapies.
Explore the latest CAR-T cell therapy advancements with impressive and effective solutions for antitumor treatments, especially against hematological malignancies from Taiwan’s key leaders in the CAR-T cell therapy industry.
Immerse in the best practices of cell & gene therapy products from the innovative showcase of the Taiwan market while considering the key factors and strategy that can lead to successful scale up and manufacturing of the products.
Listen to the key industry leaders of cell & gene therapy about their success stories of making the commercialization of the products a successful ones while replicating the strategies of effective manufacturing and commercialization in the market.
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
 6:00 PM – 7:30 PM
 23rd October 2024